Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

Prostate cancer is the most diagnosed cancer among men in the United States. While the majority of patients who undergo surgery (prostatectomy) will essentially be cured, about 30–40% men remain at risk for disease progression and recurrence. Currently, patients are deemed at risk by evaluation of c...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Vergara, Ismael A., Erho, Nicholas, Triche, Timothy J., Ghadessi, Mercedeh, Crisan, Anamaria, Sierocinski, Thomas, Black, Peter C., Buerki, Christine, Davicioni, Elai
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Frontiers Research Foundation 2012
Θέματα:
Genetics
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284255/
https://ncbi.nlm.nih.gov/pubmed/22371711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2012.00023
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια